📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Alexza

1.1 - Company Overview

Alexza Logo

Alexza

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of inhaled therapeutics for acute and intermittent conditions, featuring commercial ADASUVE (loxapine) for acute agitation in adults with schizophrenia or bipolar disorder, and developing Staccato inhalation candidates: alprazolam for epileptic seizures, apomorphine for OFF episodes in Parkinson’s disease, and granisetron for cyclic vomiting syndrome.

Products and services

  • ADASUVE: Commercial loxapine inhalation powder for acute treatment of agitation in adults with schizophrenia or bipolar disorder, administered by inhalation
  • Staccato apomorphine: Rapid-acting apomorphine product being developed for rapid treatment of OFF episodes in Parkinson’s disease patients
  • Staccato alprazolam: Proprietary inhalation technology product in development for acute treatment of epileptic seizures, delivering alprazolam through an inhaled route

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Alexza

TriSalus Logo

TriSalus

HQ: United States Website
  • Description: Provider of novel infusion systems for the interventional radiology market, including Pressure-Enabled Drug Delivery to overcome intratumoral pressure and enhance local drug concentrations; an integrated platform combining immunomodulation therapy with proprietary intravascular regional delivery for liver and pancreatic tumors; and investigational TLR9 agonist nelitolimod (SD-101), evaluated in ongoing PERIO-01 and PERIO-02 clinical trials.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full TriSalus company profile →
Milestone Scientific Logo

Milestone Scientific

HQ: United States Website
  • Description: Provider of computer-controlled injection technologies for medical and dental care, including the CompuFlo Epidural Instrument with visual/audio feedback to locate the epidural space; the STA Single Tooth Anesthesia system for precise dental delivery; DPS Dynamic Pressure Sensing and automated flow/pressure control for consistent injections.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Milestone Scientific company profile →
NTT Logo

NTT

HQ: United States Website
  • Description: Provider of practical drug delivery systems.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NTT company profile →
Liquidia Logo

Liquidia

HQ: United States Website
  • Description: Provider of biopharmaceutical therapies for pulmonary hypertension. Portfolio includes investigational treprostinil products YUTREPIA (inhaled dry powder) and L606 (sustained-release liposomal via next-generation nebulizer) for PAH and PH-ILD; a fully substitutable generic treprostinil injection for PAH promoted with Sandoz; and PRINT Technology to create precise drug particles for enhanced lung delivery.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Liquidia company profile →
Flowonix Medical Logo

Flowonix Medical

HQ: United States Website
  • Description: Provider of medical device solutions for patients with chronic disorders, featuring the Prometra Programmable Infusion Pump System, an implantable intrathecal drug delivery system indicated for use with specific medications to treat chronic pain and spasticity in adults and adolescents.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Flowonix Medical company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Alexza

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Alexza

2.2 - Growth funds investing in similar companies to Alexza

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Alexza

4.2 - Public trading comparable groups for Alexza

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Alexza

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Alexza

What does Alexza do?

Alexza is a provider of inhaled therapeutics for acute and intermittent conditions, featuring commercial ADASUVE (loxapine) for acute agitation in adults with schizophrenia or bipolar disorder, and developing Staccato inhalation candidates: alprazolam for epileptic seizures, apomorphine for OFF episodes in Parkinson’s disease, and granisetron for cyclic vomiting syndrome.

Who are Alexza's competitors?

Alexza's competitors and similar companies include TriSalus, Milestone Scientific, NTT, Liquidia, and Flowonix Medical.

Where is Alexza headquartered?

Alexza is headquartered in United States.

How many employees does Alexza have?

Alexza has 1,000 employees 🔒.

When was Alexza founded?

Alexza was founded in 2010 🔒.

What sector and industry vertical is Alexza in?

Alexza is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Alexza

Who are the top strategic acquirers in Alexza's sector and industry

Top strategic M&A buyers and acquirers in Alexza's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Alexza?

Top strategic M&A buyers groups and sectors for Alexza include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Alexza's sector and industry vertical

Which are the top PE firms investing in Alexza's sector and industry vertical?

Top PE firms investing in Alexza's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Alexza's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Alexza's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Alexza's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Alexza include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Alexza's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Alexza?

The key public trading comparables and valuation benchmarks for Alexza include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Alexza for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Alexza with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Alexza's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Alexza with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Alexza's' sector and industry vertical?

Access recent funding rounds and capital raises in Alexza's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Alexza